Correlates of NT-proBNP concentration in patients with essential hypertension in absence of congestive heart failure

Journal of Clinical Laboratory Analysis

Volumn 24, Issue 1, 2010, Pages 12-16

  Toda, Keizo ^a   Sato, Yukihito ^b   Hara, Tomoko ^a   Hijiya, Kenro ^a   Kaneko, Ryutaro ^a   Okada, Tatuo ^a   Takatsu, Yoshiki ^b   Fujiwara, Hisayoshi ^b   Iwasaki, Toshiaki ^a  

^a HYOGO PREFECTURAL AMAGASAKI GENERAL MEDICAL CENTER   (Japan)

^b Hyogo Prefectural Amagasaki Hospital   (Japan)

Author keywords

Aging; Anemia; Biomarker; Electrocardiography; Gender; Hypertension; Hypertrophy; Natriuretic peptide; Renal failure

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CREATININE; HEMOGLOBIN;

ADULT; AGED; ARTICLE; CONGESTIVE HEART FAILURE; CREATININE BLOOD LEVEL; ESSENTIAL HYPERTENSION; FEMALE; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; QRS COMPLEX;

AGE FACTORS; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; ELECTROCARDIOGRAPHY; FEMALE; GLOMERULAR FILTRATION RATE; HEART FAILURE; HEMOGLOBINS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; REGRESSION ANALYSIS; STATISTICS, NONPARAMETRIC;

EID: 75749127310     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20366     Document Type: Article

References (19)

1. Lemos JA, McGuire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease. Lancet 2003;362:316-322.
2. Liang F, Gardner DG. Mechanical strain activates BNP gene transcription through a p38/NF-κκB-dependent mechanism. J Clin Invest 1999;104:1603-1612.
3. Apple FS, Wu AHB, Jaffe AS, et al. National academy of clinical biochemistry and IFCC committee for standardization of markers of cardiac damage laboratory medicine practice guidelines: analytical issues for biomarkers of heart failure. Circulation 2007;116:e95-e98.
4. Mckie PM, Rodeheffer RJ, Cataliotti A, et al. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide Biomarkers for mortality in a large community-based cohort free of heart failure. Hypertension 2006;47:874-880.
5. Suzuki M, Yamamoto K, Watanabe S, et al. Association between elevated natriuretic peptide levels and the development of left ventricular hypertrophy in patients with hypertension. Am J Med 2000;108:627-633.
6. Wang TJ, Larson MG, Levy D, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004;350:655-663.
7. Redfield MM, Rodeheffer RJ, Jacobsen SJ, et al. Plasma brain natriuretic peptide concentration: Impact of age and gender. J Am Coll Cardiol 2002;40:976-982.
8. Hougenhuis J, Voors AA, Jaarsma T, et al. Anaemia and renal dysfunction are independently associated with BNP and NT-proBNP levels in patients with heart failure. Eur J Heart Fail 2007;9:787-794.
9. Hall C. Essential biochemistry and physiology of (NT-pro) BNP. Eur J Heart Fail 2004;6:257-260.
10. Anwaruddin S, Lloyd-Jones DM, Baggish A, et al. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement. J Am Coll Cardiol 2006;47:91-97.
11. van Kimmenade, RRJ, Januzzi JL, Bakker JA, et al. Renal clearance of B-type natriuretic peptide and amino terminal pro-B-type natriuretic peptide. JACC 2009;53:884-890.
12. Kistorp CK, Raymond I, Pedersen F, et al. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. J Am Med Assoc 2005;293:1609-1616.
13. Pedersen F, Raymond I, Kistorp C, et al. N-terminal pro-brain natriuretic peptide in arterial hypertension: a valuable prognostic marker of cardiovascular events. J Card Fail 2005;11:S70-S75.
14. Masson S, Latini R, Anand IS, et al. Direct compatison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: The valsartan heart failure (Val-HeFT) data. Clin Chem 2006;52:1528-1538.
15. Toblli JE, Lombrana A, Duarte P, et al. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. J Am Coll Cardiol 2007;50:1657-1665.
16. Anversa P, Palackal T, Sonnenblick EH, et al. Myocyte cell loss and myocyte cellular hyperplasia in the hypertrophied aging rat heart. Circ Res 1990;67:871-885
17. Matsumoto M, Tsujino T, Naito Y, et al. Anemia as a factor that elevates plasma brain natriuretic peptide concentration in apparently healthy subjects. Int Heart J 2008;49:577-586.
18. Hall C. NT-proBNP: The mechanism behind the marker. J Card Fail 2005;11:S81-S83.
19. Seki S, Tsurusaki T, Kasai T, et al. Clinical significance of B-type natriuretic peptide in the assessment of untreated hypertension. Circ J 2008;72:770-777.